Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae
- 1 January 1987
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 6 (1), 59-67
- https://doi.org/10.1016/0732-8893(87)90115-5
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Ciprofloxacin, azlocilin, ceftizoxime and amikacin alone and in combination against Gram-negative bacilli in an infected chamber modelJournal of Antimicrobial Chemotherapy, 1986
- High-Pressure Liquid Chromatographic Analysis for Quantitation of BMY-28142 and Ceftazidime in Human and Rabbit SerumJournal of Liquid Chromatography, 1986
- Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1985
- Inoculum effect of beta-lactam antibiotics on EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 1985
- Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a nentropenic site in rabbitsJournal of Antimicrobial Chemotherapy, 1985
- Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 1984
- Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organismsAntimicrobial Agents and Chemotherapy, 1983
- Ceftazidime therapy of serious bacterial infectionsAntimicrobial Agents and Chemotherapy, 1983
- Ceftazidime in the treatment of febrile immunosuppressed childrenJournal of Antimicrobial Chemotherapy, 1983
- Ceftazidime in severe infections: a Swiss multicentre studyJournal of Antimicrobial Chemotherapy, 1983